Rafa Laboratories Ltd.

9 articles about Rafa Laboratories Ltd.

• Enhancing National Preparedness: Rafa Laboratories Partners with BARDA to Advance the Development of a new design for Rafa's Pediatric Atropine Autoinjectors

  3/20/2024

  Rafa Laboratories, LTD., a leading manufacturer of Emergency Medical Solutions, and the Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services, aim to enhance the national preparedness for nerve agent emergencies by developing a new design for Rafa's pediatric atropine autoinjectors.

• U.S. Department of Defense Awards Rafa Laboratories Production FOLLOW-ON Agreement of over $45 million

  2/23/2023

  Rafa Laboratories LTD. was awarded a follow-on production agreement for a total value of over $45 million from the Defense Department's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.

• Rafa Receives FDA Approval For Life-saving Midazolam Autoinjector

  8/30/2022

  Rafa Laboratories LTD.  (" Rafa ") is pleased to announce the U.S. Food and Drug Administration has approved its "first in market" 10 mg midazolam autoinjector for the treatment of status epilepticus in adults.

• Rafa Laboratories to acquire a significant stake in ExCEEd Orphan and expand its international capabilities in medicines addressing rare diseases

  8/1/2022

  Rafa Laboratories LTD. ("Rafa") and ExCEEd Orphan s.r.o ("ExCEEd") announced today a strategic collaboration for medicines addressing rare diseases in Central and Eastern Europe ("CEE") and Israel.

• Ology Bioservices and RAFA Laboratories Announce FDA Approval of the Atropine Autoinjector as a Medical Countermeasure for Chemical Nerve Agents

  7/24/2018

  Ology Bioservices, Inc. and Rafa Laboratories, Ltd. today announced that on July 9, 2018, they received full approval from the U.S. Food and Drug Administration (FDA) for the Atropine Injection, 2mg/0.7mL, Single-Dose Autoinjector.

• Therapix And Rafa Laboratories Ltd. On The Path To Strategic Cooperation

  11/11/2016

• AEterna Zentaris And Rafa Laboratories Ltd. Sign Exclusive License Agreement For Zoptrex In Israel

  8/1/2016

• OSE Pharma To Partner Tedopi With Rafa Laboratories Ltd. For Long Term Licensing And Distribution Agreement In Israel

  5/11/2015

• Pharmaceutical Company, Rafa Builds New Jerusalem Facility

  4/22/2010